173 related articles for article (PubMed ID: 17603535)
1. More is less. New developments in funding the life sciences to make research more effective.
Hunter P
EMBO Rep; 2007 Jul; 8(7):626-8. PubMed ID: 17603535
[No Abstract] [Full Text] [Related]
2. Massachusetts pours money into local life sciences research.
Nair P
Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685583
[No Abstract] [Full Text] [Related]
3. Japanese council urges reform of funding system.
Triendl R
Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
[No Abstract] [Full Text] [Related]
4. Laying solid foundations for Europe.
Mattaj IW; Tocchini-Valentini GP
Nature; 2007 May; 447(7143):377-8. PubMed ID: 17522655
[No Abstract] [Full Text] [Related]
5. A new global strategy for the life sciences in Europe.
van Dyck L
EMBO Rep; 2005 Mar; 6(3):194-7. PubMed ID: 15741967
[TBL] [Abstract][Full Text] [Related]
6. [The report of scientific and scientific-organizational activity of Physiology Section of the Department of Biological Sciences of the Russian Academy of Sciences in 2006].
Maksimova IA; Sheremeta NG; Rosina NIa
Usp Fiziol Nauk; 2007; 38(3):87-105. PubMed ID: 17977234
[No Abstract] [Full Text] [Related]
7. [The development of European Union common research and development policy and programs with special regard to life sciences].
Pörzse G
Orv Hetil; 2009 Aug; 150(32):1509-22. PubMed ID: 19632918
[TBL] [Abstract][Full Text] [Related]
8. Prize drawback.
Nature; 2013 Feb; 494(7438):402. PubMed ID: 23451352
[No Abstract] [Full Text] [Related]
9. Setting Medical Research Future Fund priorities: assessing the value of research.
Tuffaha HW; Andronis L; Scuffham PA
Med J Aust; 2017 Feb; 206(2):63-65. PubMed ID: 28152349
[No Abstract] [Full Text] [Related]
10. City state hopes research cash will buy global status.
Fuyuno I; Cyranoski D
Nature; 2006 Jul; 442(7099):118-9. PubMed ID: 16837985
[No Abstract] [Full Text] [Related]
11. Bricks and mortar. Arizona plots a course.
Smaglik P
Nature; 2004 Apr; 428(6984):782. PubMed ID: 15085145
[No Abstract] [Full Text] [Related]
12. China: a life sciences giant.
Nat Rev Microbiol; 2010 May; 8(5):310. PubMed ID: 21080583
[No Abstract] [Full Text] [Related]
13. Medical research activities, funding, and creativity in Europe: comparison with research in the United States.
Philipson L
JAMA; 2005 Sep; 294(11):1394-8. PubMed ID: 16174700
[No Abstract] [Full Text] [Related]
14. The changing norms of the life sciences.
Shorett P; Rabinow P; Billings PR
Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
[No Abstract] [Full Text] [Related]
15. New Year's resolutions.
Nat Med; 2009 Jan; 15(1):1. PubMed ID: 19129764
[No Abstract] [Full Text] [Related]
16. Rethinking the life sciences. To better serve society, biomedical research has to regain its trust and get organized to tackle larger projects.
Swierstra T; Vermeulen N; Braeckman J; van Driel R
EMBO Rep; 2013 Apr; 14(4):310-4. PubMed ID: 23507979
[No Abstract] [Full Text] [Related]
17. France seeks to tighten its control over life sciences.
Butler D
Nature; 1995 Mar; 374(6519):206. PubMed ID: 7885435
[No Abstract] [Full Text] [Related]
18. US life sciences gets the lion's share.
Greenberg DS
Lancet; 1999 Apr; 353(9162):1421. PubMed ID: 10227237
[No Abstract] [Full Text] [Related]
19. Cancer research funding in USA.
Brown H
Mol Oncol; 2007 Sep; 1(2):128-30. PubMed ID: 19399959
[No Abstract] [Full Text] [Related]
20. Technical and social issues influencing the adoption of preprints in the life sciences.
Penfold NC; Polka JK
PLoS Genet; 2020 Apr; 16(4):e1008565. PubMed ID: 32310942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
